NEW YORK, Oct. 11, 2018 /PRNewswire-PRWeb/ -- Umbilical cord blood is now playing a critical role in the treatment of
The medical community is just beginning to discover the full potential of cord blood cells, and the next 3-5 years could produce some amazing breakthroughs for treating diseases once considered incurable. More and more, doctors and researchers are proving that cord blood cell transplants can replace diseased blood-forming cells with healthy ones.
Stem cells for transplants come from the blood of the umbilical cord collected after a baby is born. However, babies arrive into the world on their own time frame, so the logistics of cord blood collection and transportation must be carefully planned to ensure integrity and viability.
The e-book, Commercialization of Cord Blood Therapies Logistics Challenges and Solutions, written by life science logistics industry veterans Dave Murphy and Monroe Burgess, discusses some of the newest therapies and critical steps each organization should take for safe and secure transit:
"With the growing number of medical therapies currently under investigation and the encouraging results, it is clear that cord blood stem cells could change the landscape of human healthcare. We are proud to partner with pharmaceutical and biotech companies that are developing these exciting new therapies and to provide them comprehensive logistics support," says Dave Murphy, Executive Vice President, Quick Specialized Healthcare Logistics.
To help spread the word about the value of this natural resource, and the potential cord blood has to save lives, Quick is the official sponsor of World Cord Blood Day Virtual Conference (WorldCordBloodDay.org) on November 15th, 2018, featuring leading researchers and industry experts.
Quick Specialized Healthcare Logistics Quick is the trusted logistics leader for the healthcare and life science industry, serving the community for over 35 years. Quick safely and quickly transports human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices and equipment, as well as cell and gene therapies.
Contact Marie T. Vigliarolo, SVP Marketing The Quick Group +1 (718) 995-3616 ext. 2207 email@example.com quickhealthcare.aero
SOURCE Quick Specialized Healthcare Logistics
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All